Gyeongsangbuk-do, South Korea

In Cheon Hwang

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kyung Nong Corporation. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: In Cheon Hwang. Retrieved from https://idiyas.com/inventor/in-cheon-hwang-j7cg4ctl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: In Cheon Hwang: Innovator from Gyeongju-si

Introduction

In Cheon Hwang is an inventor based in Gyeongju-si, Gyeongsangbuk-do, South Korea. He is known for his contributions to the field of innovation, although he currently holds no patents. Hwang works at Lee, Yong Jin, where he collaborates with other talented individuals in the industry.

Latest Patents

As of now, In Cheon Hwang has not registered any patents. This may change in the future as he continues to develop his ideas and work on innovative projects.

Career Highlights

Hwang has built a career focused on innovation and invention. His work at Lee, Yong Jin has allowed him to explore various technological advancements and contribute to the company's goals.

Collaborations

In Cheon Hwang collaborates with notable coworkers such as Cheol Jang and Nam Gyu Kim. These partnerships enhance his creative process and foster a collaborative environment for innovation.

Conclusion

In Cheon Hwang is an emerging inventor in Gyeongju-si, Gyeongsangbuk-do, who is poised to make significant contributions to the field of innovation in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…